LUND, SE / ACCESS Newswire / June 11, 2026 / Cantargia AB (Publ) (STO:CANTA) today announced a KOL Call to be hosted in collaboration with H.C. Wainwright with leading subject matter experts Drs.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...

CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today announced that Company management will ...

Helus Pharma TM (Nasdaq: HELP) (Cboe CA: HELP), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced that Amir ...

H.C. Wainwright downgraded Summit Therapeutics (SMMT) to Neutral from Buy, citing overhang from a new late-stage trial readout for sac-TMT, a lung cancer therapy developed by Merck (MRK) in ...

Fate Therapeutics, Inc. (NASDAQ:FATE), featuring a year-to-date gain of 102.04% and upside potential of 228.30%, secures a ...

GH Research PLC (NASDAQ:GHRS) is one of the 10 Stocks That Have the Potential to Rise 1000%. On May 19, 2026, H.C. Wainwright ...

NEW YORK--(BUSINESS WIRE)--H.C. Wainwright & Co., LLC, announced its #1 Ranking by transaction volume during the third quarter of 2025, maintaining the Firm’s top position for 42 consecutive quarters, ...

GERMANTOWN, Md., March 30, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve ...

Number 1 Investment Bank for Confidentially Marketed Public Offerings, Registered Direct, Private Placement Offerings NEW YORK--(BUSINESS WIRE)--H.C. Wainwright & Co., LLC, announced its #1 Ranking by ...